Skip to main content

Paul J. Wang, MD HIP2022

Paul J. Wang, MD HIP2022

Dr. Wang is the Director of the Cardiac Arrhythmia Service and Professor of Medicine and Bioengineering (by courtesy) at Stanford University.  He is the John R. and Ai Giak L. Singleton Co-Director of the Stanford Center for Arrhythmia Research.  Dr. Wang recently became the Director of Clinical Research in the Stanford Cardiovascular Medicine Division.  He has co-authored textbooks on implantable defibrillators, sudden cardiac death, cardiac resynchronization/ biventricular pacing therapy, and innovations in arrhythmia therapy. Dr. Wang serves as the Editor-in-Chief of Circulation: Arrhythmia and Electrophysiology.  Dr. Wang received the 2017 AHA Council on Clinical Cardiology Distinguished Achievement Award. Dr. Wang serves as the Center Director of the AHA Atrial Fibrillation SFRN DECIDE Grant and the Project Director of the AHA Health Technologies and Innovation SFRN Grant and the AHA Diversity in Clinical Trials SFRN Grant. Dr. Wang serves on the AHA Clinical Cardiology Council and previously served on the AHA Council Operations Committee, the AHA Diversity Committee of the Council Operations Committee, and the AHA National Science and Life Long Learning Committee. Dr. Wang’s research centers on developing innovative treatments of arrhythmias, including catheter ablation, implantable devices, and diagnostic techniques.   He is a former member of the Board of Trustees of the Heart Rhythm Society.


Dr. Wang has 20 issued patents.  Dr. Wang is co-inventor of a cryoablation method and device that has been the basis of a cryoablation catheter which has been FDA approved (Cryocath, Inc. acquired by Medtronic, Inc.).  Catheter cryoablation has been used in over 1 million patients with atrial fibrillation and supraventricular tachycardias. Dr. Wang recently completed the Stanford Biodesign-Fogarty Innovation Accelerator Program and has received Stanford SPECTRUM and Coulter Foundation grants to support his work in innovation. Dr. Wang is participating in a Stanford Medicine Catalyst Program to advance new technologies.


Dr. Wang is Co-Director of the Bioengineering Scholarly Concentration of the Stanford School of Medicine.   Dr. Wang directs the course Bioengineering 390, Introduction to Bioengineering Research.  Dr. Wang organizes an annual meeting, “Stanford Biodesign New Arrhythmia Technologies Retreat”, focusing on new technological advances in arrhythmia management and diagnosis.  Dr. Wang also teaches a Stanford Introsems Course Bioengineering 72N, “Pathophysiology and Design in Cardiovascular Disease,” which introduces undergraduates to the cardiovascular medicine and Biodesign innovation principles.  Dr. Wang helped found the Stanford Biodesign Faculty Fellows Program, which trains Stanford faculty in medical device and technology innovation.  Dr. Wang is a member of the Stanford Biodesign Center program committee and the Center’s Faculty Liaison.

Dr. Wang is a member of the Stanford Cardiovascular Institute and the Stanford Center for Asian Research and Education and serves as its Editor-in-Chief of the Journal of Asian Health.

More News

Sign up for our mailing list